| 000 | 01749 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250512092125.0 | ||
| 264 | 0 | _c19741111 | |
| 008 | 197411s 0 0 eng d | ||
| 022 | _a0024-5461 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrannon, D R | |
| 245 | 0 | 0 |
_aMicrobial production of pharmacologically active compounds other than antibiotics. _h[electronic resource] |
| 260 |
_bLloydia _cJun 1974 |
||
| 300 |
_a134-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aActinomycetales _xmetabolism |
| 650 | 0 | 4 |
_aAminobutyrates _xmetabolism |
| 650 | 0 | 4 |
_aBrain _xenzymology |
| 650 | 0 | 4 |
_aCarbonic Anhydrase Inhibitors _xisolation & purification |
| 650 | 0 | 4 | _aCatechol O-Methyltransferase Inhibitors |
| 650 | 0 | 4 |
_aCatecholamines _xmetabolism |
| 650 | 0 | 4 | _aComplement Inactivator Proteins |
| 650 | 0 | 4 | _aCulture Media |
| 650 | 0 | 4 |
_aCyclic AMP _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDopamine beta-Hydroxylase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aEnzyme Inhibitors |
| 650 | 0 | 4 | _aFiltration |
| 650 | 0 | 4 |
_aFungi _xmetabolism |
| 650 | 0 | 4 |
_aGlucuronidase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aHistamine H1 Antagonists _xisolation & purification |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xisolation & purification |
| 650 | 0 | 4 |
_aNeuraminidase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPharmaceutical Preparations _xclassification |
| 650 | 0 | 4 | _aProtease Inhibitors |
| 650 | 0 | 4 | _aSpectrophotometry |
| 650 | 0 | 4 |
_aTryptophan Hydroxylase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xantagonists & inhibitors |
| 700 | 1 | _aFuller, R W | |
| 773 | 0 |
_tLloydia _gvol. 37 _gno. 2 _gp. 134-46 |
|
| 999 |
_c4158402 _d4158402 |
||